We detected PDIA5 expression in GBM and pan-gliomas samples from the TCGA dataset and found that increased PDIA5 expression was associated with the CL and ME molecular subtypes (Supplementary Figure S1G). The gene discussed is PDIA5; the disease is central nervous system cancer.